Article
Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes.
Diabetes care - 1 Dec 2014
Myngheer Nele, Allegaert Karel, Hattersley Andrew, McDonald Tim, Kramer Holger, Ashcroft Frances M, Verhaeghe Johan, Mathieu Chantal, Casteels Kristina
Abstract excerpt
OBJECTIVE: Sulfonylureas (SUs) are effective at controlling glycemia in permanent neonatal diabetes mellitus (PNDM) caused by KCNJ11 (Kir6.2) mutations. RESEARCH DESIGN AND METHODS: We report the case of a woman with PNDM who continued high doses of glibenclamide (85 mg/day) during her pregnancy. The baby was born preterm, and presented with macrosomia and severe hyperinsulinemic hypoglycemia requiring high-rate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
